Coronavirus (359) COVID-19 study register

7 April, 2020

Dear HIFA members,

Cochrane launched today its COVID-19 Study Register - a register with primary research studies on COVID-19. https://covid-19.cochrane.org/

The aim of the register is to support rapid evidence synthesis by all systematic review producers, including Cochrane's work on Rapid Reviews in response to COVID-19. The register helps systematic reviewers prioritize topics, identify available evidence, and produce urgently needed reviews for front-line health professionals, public health policymakers, and research teams developing new therapeutic, diagnostic, and preventive interventions for COVID-19.

The new COVID-19 Study Register will be continually updated with human studies on COVID-19. More background information about the register can be found here: https://community.cochrane.org/about-covid-19-study-register

Please direct any questions or comments about Cochrane's COVID-19 Study Register to covid-19-register@cochrane.org

With best wishes,

Sylvia

Sylvia de Haan

Head of External Affairs & Geographic Groups’ Support

Chief Executive’s Office

Cochrane Central Executive

E sdehaan@cochrane.org T +31 6 24489499 S sylviadehaan31

www.cochrane.org

Trusted evidence. Informed decisions. Better health.

The Cochrane Collaboration. Registered in England as a company limited by guarantee No. 03044323 Charity Number 1045921. VAT registration number GB 718 2127 49. Registered office: St Albans House, 57-59 Haymarket, London SW1Y 4QX United Kingdom

HIFA profile: Sylvia de Haan is Partnerships Coordinator at Cochrane, and is based in the Netherlands. Email address: sdehaan AT cochrane.org